atazanavir 300 MG / cobicistat 150 MG Oral Tablet [Evotaz]
RxNorm concept 1601660, branded drug (sbd). Prescribable name: EVOTAZ 300 MG / 150 MG Oral Tablet.
- RxCUI
- 1601660
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1601660 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Evotaz (atazanavir 300 MG (as atazanavir sulfate 342 MG) / cobicistat 150 MG) Oral Tablet
Related concepts
- atazanavir 300 MG (SCDC, consists of)
- cobicistat 150 MG (SCDC, consists of)
- atazanavir 300 MG / cobicistat 150 MG [Evotaz] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- Evotaz (BN, has ingredient)
- atazanavir 300 MG / cobicistat 150 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1601660 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1601660 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1601660. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.